Emory University Neurocrine Biosciences Inc Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $2.43 Million - $2.95 Million	-29,020 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $52,951 - $66,900	733 Added 2.59%	29,020 $2.45 Million
Q1 2019 May 09, 2019	BUY	$69.31 - $91.53 $207,791 - $274,406	2,998 Added 11.85%	28,287 $2.49 Million
Q4 2018 Feb 12, 2019	BUY	$68.32 - $124.36 $1.73 Million - $3.14 Million	25,289 New	25,289 $1.81 Million

640

95.2M

661K

227K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.